Scientech Research LLC Alkermes Plc. Put Options Transaction History
Scientech Research LLC
- $189 Billion
- Q1 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding ALKS
# of Institutions
356Shares Held
180MCall Options Held
522KPut Options Held
463K-
Black Rock Inc. New York, NY29.2MShares$671 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.2MShares$464 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$343 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$207 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$192 Million0.03% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $3.78B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...